ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND vs Mirae Asset Nifty 500 Healthcare ETF
ABSL vs Mirae· Portfolio Overlap Analysis
57.3%High Overlap
27 common stocksRank #6034 / 20,000
Investor takeaway: At 57.3% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.
Common Holdings (27)
| Stock | Wt% in ADITYA BIRLA SUN LIFE PHARMA & | Wt% in Mirae Asset Nifty 500 Healthca | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology | 13.34% | 10.02% | 10.02% |
Apollo Hospitals Enterprise Limited Healthcare Services | 7.78% | 6.72% | 6.72% |
Lupin Limited Pharmaceuticals & Biotechnology | 4.21% | 4.66% | 4.21% |
Fortis Healthcare Limited Healthcare Services | 4.17% | 4.10% | 4.10% |
Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 5.20% | 3.78% | 3.78% |
Cipla Limited Pharmaceuticals & Biotechnology | 3.59% | 6.33% | 3.59% |
Aurobindo Pharma Limited Pharmaceuticals & Biotechnology | 4.16% | 2.85% | 2.85% |
Alkem Laboratories Limited Pharmaceuticals & Biotechnology | 2.31% | 2.75% | 2.31% |
Mankind Pharma Ltd Pharmaceuticals & Biotechnology | 2.65% | 2.12% | 2.12% |
Divi's Laboratories Limited Pharmaceuticals & Biotechnology | 1.95% | 6.80% | 1.95% |
IPCA Laboratories Limited Pharmaceuticals & Biotechnology | 3.94% | 1.77% | 1.77% |
Dr. Reddys Laboratories Limited Pharmaceuticals & Biotechnology | 1.49% | 6.54% | 1.49% |
J.B. Chemicals & Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 4.99% | 1.40% | 1.40% |
Biocon Limited Pharmaceuticals & Biotechnology | 1.24% | 2.32% | 1.24% |
SAI Life Sciences Ltd Pharmaceuticals & Biotechnology | 2.16% | 1.14% | 1.14% |
Abbott India Limited Pharmaceuticals & Biotechnology | 4.02% | 1.13% | 1.13% |
Gland Pharma Limited Pharmaceuticals & Biotechnology | 1.07% | 1.21% | 1.07% |
Ajanta Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 4.53% | 1.05% | 1.05% |
Max Healthcare Institute Limited Healthcare Services | 0.90% | 6.78% | 0.90% |
GlaxoSmithKline Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 0.99% | 0.89% | 0.89% |
Piramal Pharma Ltd Pharmaceuticals & Biotechnology | 1.06% | 0.81% | 0.81% |
Pfizer Limited Pharmaceuticals & Biotechnology | 1.08% | 0.64% | 0.64% |
Jubilant Pharmova Ltd Pharmaceuticals & Biotechnology | 1.19% | 0.58% | 0.58% |
METROPOLIS HEALTHCARE LIMITED Healthcare Services | 1.50% | 0.41% | 0.41% |
Vijaya Diagnostic Centre Limited Healthcare Services | 0.92% | 0.41% | 0.41% |
Emcure Pharmaceuticals Ltd Pharmaceuticals & Biotechnology | 3.03% | 0.36% | 0.36% |
ALEMBIC PHARMACEUTICALS LIMITED Pharmaceuticals & Biotechnology | 1.34% | 0.33% | 0.33% |
Unique to ADITYA BIRLA SUN LIFE PHARMA &
All top holdings are shared with the other fund.
Unique to Mirae Asset Nifty 500 Healthca
- Laurus Labs Ltd.3.49%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology44.7% (22)
Healthcare Services12.5% (5)
More comparisons for ADITYA BIRLA SUN LIFE PHARMA &
- vs NIPPON INDIA PHARMA61.7% · 25 stocks
- vs Motilal Oswal BSE Healthcare E58.0% · 33 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE55.9% · 16 stocks
- vs Axis NIFTY Healthcare ETF55.9% · 16 stocks
- vs ICICI Prudential Nifty Healthc55.9% · 16 stocks
More comparisons for Mirae Asset Nifty 500 Healthca
- vs Motilal Oswal BSE Healthcare E88.9% · 50 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE78.3% · 20 stocks
- vs Axis NIFTY Healthcare ETF78.3% · 20 stocks
- vs DSP Nifty Healthcare ETF78.3% · 20 stocks
- vs ICICI Prudential Nifty Healthc78.3% · 20 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.